anxiety
ANXIETY

Anxiety disorders are disorders wherein the patient experiences uncontrollable fear or anxiety with behavioral disturbances that affects normal functioning.

Generalized anxiety disorder is having excessive anxiety and worry occurring for at least 6 months about several events or activities. The person finds it difficult to control the worry.
Panic disorder is when the person experienced recurrent unexpected panic attacks.
Social anxiety disorder is marked and persistent fear of social or performance situations in which the person is exposed to unfamiliar people or to possible scrutiny by others.

  1. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005 Nov;19(6):567-596. PMID: 16272179
  2. Bruce TJ, Saeed SA. Social anxiety disorder: a common under-recognized mental disorder. Am Fam Physician. 1999 Nov;60(8):2311-2322. PMID: 10593322
  3. Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry. 2006 Jul;51(8)(Suppl 2):9S-91S. PMID: 16933543
  4. Culpepper L. Use of algorithms to treat anxiety in primary care. J Clin Psychiatry. 2003;64(Suppl 2):30-33. PMID: 12625797
  5. Gliatto MF. Generalized anxiety disorder. Am Fam Physician. 2000 Oct;62(7):1591-1600. PMID: 11037076
  6. Gorman JM. Treating generalized anxiety disorder. J Clin Psychiatry. 2003;64(Suppl 2):24-29. PMID: 12625796
  7. Hicks D, Cummings T Jr, Epstein SA. An approach to the patient with anxiety. Med Clin North Am. 2010 Nov;94(6):1127-1139. PMID: 20951274
  8. Kavan MG, Elsasser G, Barone EJ. Generalized anxiety disorder: practical assessment and management. Am Fam Physician. 2009 May;79(9):785-791. PMID: 20141098
  9. Lepine JP. The epidemiology of anxiety disorders: prevalence and societal costs. J Clin Psychiatry. 2002;63(Suppl 14):004-8. PMID: 12562112
  10. Hidalgo RB, Davidson JR. Generalized anxiety disorder. An important clinical concern. Med Clin North Am. 2001 May;85(3):691-710. PMID: 11349480
  11. Radomsky AS, Otto MW. Cognitive-behavioral therapy for social anxiety disorder. Psychiatr Clin North Am. 2001 Dec;24(4):805-815. PMID: 11723634
  12. Rickels K, Rynn M. Pharmacotherapy of generalized anxiety disorder. J Clin Psychiatry. 2002;63(Suppl 14):009-16. PMID: 12562113
  13. Raj BA, Sheehan DV. Social anxiety disorder. Med Clin North Am. 2001 May;85(3):711-733. PMID: 11349481
  14. Rickels K, Moller HJ. Anxiety: new treatment perspectives [introduction]. J Clin Psychiatry. 2002;63(Suppl 14):3
  15. Schneider FR. Clinical practice: social anxiety disorder. N Engl J Med. 2006 Sep;335(10):1029-1036. PMID: 16957148
  16. Sheehan DV. The management of panic disorder. J Clin Psychiatry. 2002;63(Suppl 14):17-21. PMID: 12562114
  17. Van Ameringen M. Pharmacotherapy of social anxiety disorder at the turn of the millennium. Psychiatr Clin North Am. 2001 Dec;24(4):783-803. PMID: 11723633
  18. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  19. MedWormhttp://www.medworm.com/rss/index.php/Psychiatry/172/http://www.medworm.com/rss/medicalfeeds/specialities/Psychiatry.xml
  20. Stein MB, Goin MK, Pollack MH, et al, for the Work Group on Panic Disorder. American Psychiatric Association (APA). Practice guideline for the treatment of patients with panic disorder. 2nd ed. 2009
  21. Ministry of Health Singapore and National Medical Research Council. Clinical practice guideline: anxiety disorders. http://www.moh.gov.sg/content/moh_web/home.html. Nov 2003
  22. Questionnaires. Identifying Depression as a Comorbid Condition Website. http://idacc.healthbase.info/questionnaires.html. Accessed 05 Aug 2013
  23. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: Management in primary, secondary and community care. CG 113. NICE. http://publications.nice.org.uk. Jan 2011.
  24. Institute for Clinical Systems Improvement (ICSI). Health care guideline: major depression, panic disorder and generalized anxiety disorder in adults in primary care: collaborative decision-making management. http://www.icsi.org. May 2002
  25. The Guideline Development Group, National Collaborating Centre and NICE project team. Social anxiety disorder: recognition, assessment and treatment. http://www.nice.org.uk. May 2013. Accessed 01 Aug 2013.
  26. McIntosh A, Cohen A, Turnbull N, et al. Clinical guidelines for the management of anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. NICE. http://www.nice.org.uk. Dec 2004.
  27. American Psychiatric Association. Anxiety Disorders. In: Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013:190-222.
  28. Bandelow B, Sher L, Benevicius R, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. doi: 10.3109/13651501.2012.667114. PMID: 22540422
  29. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(Suppl 1):S1. doi: 10.1186/1471-244X-14-S1-S1. PMID: 25081580
  30. Ministry of Health Singapore. Clinical practice guidelines anxiety disorders. MOH Singapore. http://www.moh.gov.sg/cpg. 2015 Jan.
  31. Stahl SM. Stahl’s essential psychopharmacology: neuroscientific basis and practical application. 4th ed. Cambridge, United Kingdom: Cambridge University Press; 2013:111.
  32. Bystritsky A. Pharmacotherapy for generalized anxiety disorder in adults. UpToDate. www.uptodate.com. 2016 Apr.
  33. Kreys TJ, Phan SV. A literature review of quetiapine for generalized anxiety disorder. Pharmacotherapy. 2015 Feb;35(2):175-188. doi: 10.1002/phar.1529. Accessed 10 Aug 2016. PMID: 25689246
  34. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014 May;28(5):403-439. doi: 10.1177/0269881114525674. PMID: 24713617
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
Yesterday
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, 2 days ago
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, 2 days ago
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.